<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04306107</url>
  </required_header>
  <id_info>
    <org_study_id>10-03-2020</org_study_id>
    <secondary_id>10-03-2020 2</secondary_id>
    <nct_id>NCT04306107</nct_id>
  </id_info>
  <brief_title>Prone Position in Non-Invasive Ventilation and High-Flow Oxygen Therapy</brief_title>
  <acronym>ProPNIVFlow</acronym>
  <official_title>Prone Position in Non-Invasive Ventilation and High-Flow Oxygen Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital General Universitario Morales Meseguer</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital General Universitario Morales Meseguer</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this trial is to study the effect of prone position during NIV and HFNC on acute
      hypoxemic respiratory patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inclusion Criteria:

      Adult patients with:

      â€¢ ARDS/pneumonia/acute hypoxemic respiratory failure with PaO2/FiO2 between 150 and 300 (on 5
      cmH2O PEEP level)

      Exclusion Criteria

        -  General NIV or HFNC contraindications

        -  Immediate need for IOT

        -  Prone position intolerance

        -  Patients refusal to participate

      Interventions:

        -  Prone position for 2-4 hours twice a day, for 3 days (first 3 days since admission to
           ICU)

        -  Nurse surveilance: at least every 15 minutes

      Outcomes:

        -  Need for IOT

        -  Effects on the measurements specified above (particularly PaO2/FiO2)
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2020</start_date>
  <completion_date type="Anticipated">May 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oro-tracheal entubation</measure>
    <time_frame>1 month</time_frame>
    <description>Oro-tracheal entubation avoidance</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PaO2/FiO2</measure>
    <time_frame>1 month</time_frame>
    <description>Effect of prone position on PaO2/FiO2</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Evaluation of Prone Position Effect During NIV and HFNC on Acute Hypoxemic Respiratory Failure</condition>
  <arm_group>
    <arm_group_label>NIV with prone position</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of prone position during NIV</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NIV (conventional)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>NIV on conventional position</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HFNC on prone position</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Prone position during HFNC</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HFNC (conventional)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>HFNC on conventional position</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Prone position during non-invasive respiratory support</intervention_name>
    <description>HFNC and NIV application with patient on prone position</description>
    <arm_group_label>HFNC (conventional)</arm_group_label>
    <arm_group_label>HFNC on prone position</arm_group_label>
    <arm_group_label>NIV (conventional)</arm_group_label>
    <arm_group_label>NIV with prone position</arm_group_label>
    <other_name>HFNC and NIV application with patient on prone position</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients with:

               -  ARDS/pneumonia/acute hypoxemic respiratory failure with PaO2/FiO2 between 150 and
                  300 (on 5 cmH2O PEEP level)

        Exclusion Criteria:

          -  General NIV or HFNC contraindications

          -  Immediate need for IOT

          -  Prone position intolerance

          -  Patients refusal to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Miguel Guia, MD</last_name>
    <phone>00351915774975</phone>
    <phone_ext>00351915774975</phone_ext>
    <email>miguelguia7@gmail.com</email>
  </overall_contact>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 10, 2020</study_first_submitted>
  <study_first_submitted_qc>March 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 12, 2020</study_first_posted>
  <last_update_submitted>March 10, 2020</last_update_submitted>
  <last_update_submitted_qc>March 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital General Universitario Morales Meseguer</investigator_affiliation>
    <investigator_full_name>Miguel Filipe Martins de Matos Navarro Guia</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Noninvasive ventilation</keyword>
  <keyword>High-flow nasal oxygen therapy</keyword>
  <keyword>Prone position</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

